Skip to main content


Featured Article
As of October 1, 2019, the number of lung injury cases associated with vaping products has increased to 1080, with the death count increasing from 12 to 18.
According to AstraZeneca, the FDA has declined to approve its combination therapy used for the treatment of smoker's lung.


Michael Cawley, PharmD, discusses a recently approved digitized respiratory inhaler and explains why health care providers should consider how this new technology will track personal data.
“In view of the increasing popularity of e-cigs, especially among adolescents…these findings have significant implications for public health and tobacco regulatory science,” says Ahmad Besaratinia, PhD, associate professor of research preventive…
Back to Top